ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Journal and News Scan
March 28, 2015
Submitted by: Stuart Head
Benedetto and co-authors analyzed propensity-matched groups of patients who underwent CABG or PCI (n= 1097 pairs) for multivessel disease, and found that outcomes were comparable at 1-year follow-up, while CABG did significantly better during follow-up to 5 years and Kaplan-Meier curves continued to diverge even further after 5 years.
March 28, 2015
Submitted by: Stuart Head
In a prospective study using MRI before and within 14 days after AVR and TAVI, Crouch and co-authors demonstrated that postoperative aortic regurgitation that was higher in the TAVI group had a significant impact on increasing left atrial size and declining right ventricular function.
March 27, 2015
Submitted by: Mark Ferguson
The authors evaluated a simple scoring system for assessing sternal healing after sternotomy. Observers had close agreement as to how CT findings matched the scoring system. There was no attempt at correlating CT findings with clinical results. Healing scores increased over time, indicating some correlation with biologic behavior.
March 21, 2015
Submitted by: Marcelo Jimenez
Concerns remain about the definition of a high risk population who can benefit from low-dose computed tomography screening programs. In this paper, the authors present a promising tool to optimize lung cancer screening in a high-risk population using a serum microRNA signature (miR-Test). The area under the ROC curve of test is 0.85 (95% CI = 0.78 to 0.92).
March 21, 2015
Submitted by: J. Rafael Sadaba
The authors describe the one-year results of a randomized trial comparing outcomes between transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) among an all-comers cohort of 280 patients. Patients 70 years of age or older with severe degenerative aortic valve stenosis referred for SAVR but also a candidate for TAVR were eligible for inclusion regardless of their predicted risk of death after surgery. The primary hypothesis was that the rate of the composite outcome of death from any cause, stroke, or myocardial infarction after 1 year would be lower for patients receiving TAVR versus SAVR. In the intent-to-treat analysis, the primary outcome was similar in the two groups (13.1% vs.16.3% for TAVR and SAVR). The need for permanent pacemaker implantation was higher in TAVR patients (38.0% vs. 2.4%), while the rate of new-onset or worsening atrial fibrillation was lower (21.2% vs. 59.4%). After 1 year, patients undergoing TAVR had more dyspnea compared to SAVR patients (29.5% vs. 15.0%; P=0.01). There was more improvement in effective orifice area relative to baseline in SAVR patients, but TAVR patients experienced a higher rate of significant aortic valve regurgitation. The authors conclude that based on their findings, they are not able to recommend one procedure over the other in lower risk patients.
March 17, 2015
Submitted by: Mark Ferguson
The authors sought to validate the definition of the systemic inflammatory response syndrome (SIRS), which requires the presence of 2 or more clinical criteria, and determined whether meeting the definition was associated with an increased risk of death. Over 109,000 ICU patients in Australia and New Zealand who had infection and organ failure were studied. 88% had SIRS positive sepsis, the others did not meet the SIRS criteria (SIRS negative sepsis). Mortality in the two groups decreased similarly over the 14 year study. There was a linear increase in mortality associated with each additional SIRS criterion, indicating that the threshold of 2 criteria did not represent a transition in risk level.
March 17, 2015
Submitted by: Mark Ferguson
The study investigated management of atrial fibrillation existing at the time of mitral valve surgery, randomizing 260 pts to ablation or observation. The end point was freedom from afib at both 6 and 12 mos. Ablation yielded success in 63% compared to 29% of controls, but was associated with a higher risk of pacemaker implant (21% vs 8%).
March 16, 2015
Submitted by: Mark Ferguson
This Netherlands population-based study followed causes of death in patients with NSCLC diagnosed 1989-2008, including more than 72,000 patients. For those with localized disease, lung cancer was the cause of death in 80-85% for years 0-3, 60-75% for years 4-6, and remained the cause of death for more than 30% thereafter. After 6 years CAD and COPD became the primary causes of death.
March 16, 2015
Submitted by: Mark Ferguson
The authors describe results of initial bronchoscopy therapy (IBT) for endobronchial carcinoids aimed at relieving obstruction, accurate subtyping, and potentially complete eradication. After a minimum follow-up of 5 years, 42% of patients were spared surgical therapy, having had no evidence of local or distant recurrence (42/83 with typical histology, 5/29 with atypical histology).
March 16, 2015
Submitted by: J. Rafael Sadaba
In this manuscript the authors present a post-hoc study of the SYNTAX trial. They compare outcomes between those patients on optimal medical therapy (OMT) and non-optimal medical therapy following revascularization for complex coronary artery disease (CAD). OMT was defined as combination of at least one antiplatelet drug, statin, beta-blocker and angiotensin converting enzyme inhibitor/angiotensin receptor blocker (ACE-I/ARB). Only one third of the patients were found to be on OMT at 5-year follow up. Lack of OMT was associated with a higher mortality and combined endpoint of death, MI and stroke. These findings reinforce the the importance of OMT use for patients with complex CAD undergoing revascularization.